Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Liver Cirrhosis × Lymphoid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 7 Lymphoid 1

Conditions

Lymphoma, Non-Hodgkin 678 Lymphoma 638 Leukemia, Lymphocytic, Chronic, B-Cell 504 Lymphoma, Follicular 458 Lymphoma, Large B-Cell, Diffuse 396 Precursor Cell Lymphoblastic Leukemia-Lymphoma 299 Recurrence 280 Lymphoma, B-Cell 256 Neoplasms 229 Lymphoma, Mantle-Cell 226 Leukemia 206 Multiple Myeloma 167 Leukemia, Myeloid, Acute 160 Hodgkin Disease 152 Lymphoma, B-Cell, Marginal Zone 125 Lymphoma, T-Cell, Peripheral 105 Burkitt Lymphoma 96 Hematologic Neoplasms 91 Myelodysplastic Syndromes 90 Lymphoma, T-Cell, Cutaneous 79 Waldenstrom Macroglobulinemia 74 Leukemia, B-Cell 73 Lymphoma, T-Cell 66 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 61 Hematologic Diseases 51 Carcinoma, Non-Small-Cell Lung 50 Lymphoproliferative Disorders 49 Breast Neoplasms 47 Melanoma 46 Mycosis Fungoides 44

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06812780 2025-09-24

CAMPOLINA

AstraZeneca

Phase 1 Completed

Liver Cirrhosis, Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡